Tag: Cancer research
FDA approves imaging drug for detecting cancer after lumpectomy
Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…
Two scandals at Harvard spotlight data fabrication problem in academic research
Editor's Note Two separate incidents of data fabrication and manipulation involving Harvard University and its affiliates might be indicative of a much larger fraud problem in the scientific research world, Vox March 1 reports. The most recent of the two incidents happened at the Harvard-affiliated Dana-Farber Cancer Institute, which faced…
Free Daily News
- Take the OR Manager Career/Salary Survey, help shape the future of perioperative leadership
- Virtual care, tech-enabled roles reshape nursing as leaders diverge on care redesign priorities
- As healthcare faces skyrocketing cyberattacks, surgeons are urged to lead frontline defense
- Study shows WHO surgical checklist boosts safety, but compliance gaps risk patient outcomes
- Kentucky Derby, SPD race: Leadership lessons energized SPD professionals at HSPA 2025
- Continuum-based protocol offers new strategy for preventing PONV after thyroidectomy
- Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows
- Subarachnoid spinal anesthesia offers safe, effective option for high-risk obstetric patients
- Same-day discharge after catheter ablation gains backing from top cardiology societies
- Tenet, HCA post strong Q1 results, but caution looms over policy uncertainty, outpatient trends
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement